WESTBY KEITH (SVP & COO) sold 33.5% of their position (20K shares) of IVERIC BIO, INC. on the open market
Open‑market sale worth $789.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/6/2023ACC: 0001410939-23-000105
-20K
Net shares
Net seller
$789.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$2.94
Trade value
$58.80K
% of position
50.4%
7/3/2023
39.65K→59.65K
Common Stock
Direct
Shares
−20K
Price / share
$39.45
Trade value
$789K
% of position
33.5%
7/3/2023
59.65K→39.65K
Total
Net shares
+0.00
Net value
-$730.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/3/2023 | M · Option Exercise | +20K | $2.94 | $58.80K | 50.4% | 39.65K | 59.65K |
| Common Stock Direct | 7/3/2023 | S · Sale | −20K | $39.45 | $789K | 33.5% | 59.65K | 39.65K |
| Total | +0.00 | -$730.20K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
2.94
Held after
80K
Exercisable
—
7/3/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20K shares | 7/3/2023 | M · Option Exercise | −20K | 2.94 | — | 80K |